- Service Name
Affibody Medical AB
- Industry
Biotechnology, Biopharmaceuticals, Therapeutics, Diagnostics
- Main Value Proposition
Affibody offers advanced biopharmaceutical solutions that leverage its unique technology platform to address unmet medical needs in therapy and diagnostics.
- Description
Affibody is a Swedish biotechnology company that specializes in developing next-generation biologics and biopharmaceuticals. The company focuses on innovative therapeutic solutions, particularly in the fields of therapy and diagnostic imaging.
- Key Features
Proprietary technology platform; Broad pipeline of innovative products; Focus on therapeutic and diagnostic applications; Recognition as an innovator in engineered multi-specific antibodies
- Use Cases
Therapeutic applications in oncology; Diagnostic imaging solutions; Development of advanced drug delivery systems
- Competitive advantages
Strong focus on innovative biologics and therapeutic solutions; Recognition in the pharmaceutical industry for advanced engineered antibodies; A broad and strategically focused pipeline that targets high-impact medical needs
- Strengths
Affibody's strengths lie in its innovative technology, a diverse product pipeline, and its commitment to addressing significant medical challenges through advanced biopharmaceuticals.
- Positioning
Affibody positions itself as a leader in the biotechnology industry, focusing on the development of next-generation biopharmaceuticals that leverage proprietary technology for enhanced therapeutic efficacy.
- Audience
The primary target users include healthcare professionals, researchers in biotechnology, and pharmaceutical companies looking for innovative therapeutic solutions.
- CTA
Contact us
- Tags
biopharmaceuticals
biotechnology
therapeutics
diagnostics
- Tagline
The next generation biopharmaceuticals
- Tone of Voice
Innovative, professional, authoritative
- Differentiation
Affibody's unique proprietary technology platform allows for the development of biologics that are tailored for specific therapeutic applications, setting it apart from competitors in the biotechnology sector.
- Brand Positioning
Affibody's brand identity is centered around innovation, scientific excellence, and a commitment to improving patient outcomes through advanced biopharmaceuticals.
- Founded
1998-01-01
- Founders
Mathias Uhlén